Akcea Therapeutics, Inc. (AKCA) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
22 BOSTON WHARF RD BOSTON, MA 02210 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2020 MRQ | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments, including: | 463,700 | 252,600 | 260,130 | |||
| Cash and cash equivalents | 306,866 | 86,454 | 58,367 | |||
| Short-term investments | 156,806 | 166,155 | 201,763 | |||
| Other undisclosed cash, cash equivalents, and short-term investments | 28 | (9) | ||||
| Receivables | 3,231 | 4,597 | 5,413 | |||
| Inventory, net of allowances, customer advances and progress billings | 8,817 | |||||
| Inventory | 8,817 | |||||
| Contract with customer, asset, after allowance for credit loss | 10,496 | ✕ | ||||
| Other current assets | 10,689 | 10,029 | 1,302 | |||
| Other undisclosed current assets | (28) | 9 | ||||
| Total current assets: | 496,905 | 267,235 | 266,845 | |||
| Noncurrent Assets | ||||||
| Operating lease, right-of-use asset | 11,094 | ✕ | ✕ | |||
| Property, plant and equipment | 5,261 | 5,696 | 77 | |||
| Intangible assets, net (including goodwill) | 83,051 | 88,914 | 1,221 | |||
| Intangible assets, net (excluding goodwill) | 83,051 | 88,914 | 1,221 | |||
| Other noncurrent assets | 2,939 | 3,416 | 661 | |||
| Total noncurrent assets: | 102,345 | 98,026 | 1,959 | |||
| TOTAL ASSETS: | 599,250 | 365,261 | 268,804 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 37,200 | 35,438 | 14,034 | |||
| Employee-related liabilities | 12,793 | 8,583 | 4,083 | |||
| Accounts payable | 10,216 | 12,068 | 2,381 | |||
| Accrued liabilities | 14,191 | 14,787 | 7,570 | |||
| Deferred revenue | 2,165 | ✕ | ✕ | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 50,579 | ||
| Due to related parties | 18,901 | 14,365 | ||||
| Contract with customer, liability | ✕ | ✕ | 25,354 | ✕ | ||
| Other liabilities | 2,633 | 968 | 1,875 | |||
| Total current liabilities: | 41,998 | 80,661 | 80,853 | |||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation: | 14,248 | |||||
| Liabilities, other than long-term debt | 7,876 | 8,318 | ||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 8,318 | ||
| Contract with customer, liability | ✕ | ✕ | 3,434 | ✕ | ||
| Deferred rent credit | 4,442 | ✕ | ||||
| Operating lease, liability | 14,248 | ✕ | ✕ | |||
| Total noncurrent liabilities: | 14,248 | 7,876 | 8,318 | |||
| Total liabilities: | 56,246 | 88,537 | 89,171 | |||
| Equity | ||||||
| Equity, attributable to parent | 543,004 | 276,724 | 179,633 | |||
| Common stock | 101 | 89 | 67 | |||
| Additional paid in capital | 1,024,168 | 799,001 | 464,430 | |||
| Accumulated other comprehensive income (loss) | 5 | (324) | (451) | |||
| Accumulated deficit | (481,270) | (522,042) | (284,413) | |||
| Total equity: | 543,004 | 276,724 | 179,633 | |||
| TOTAL LIABILITIES AND EQUITY: | 599,250 | 365,261 | 268,804 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|
| Revenues | 488,543 | 64,867 | 55,209 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (2,713) | ||||
| Gross profit: | 488,543 | 62,154 | 55,209 | ||
| Operating expenses | (474,533) | (295,683) | (163,871) | ||
| Other undisclosed operating income | 24,064 | 2,713 | |||
| Operating income (loss): | 38,074 | (230,816) | (108,662) | ||
| Nonoperating income | 4,890 | 5,442 | 1,917 | ||
| Investment income, nonoperating | 5,505 | 5,631 | 1,813 | ||
| Interest and debt expense | (1,731) | ||||
| Income (loss) from continuing operations before income taxes: | 42,964 | (225,374) | (108,476) | ||
| Income tax expense | (2,192) | (447) | (1,275) | ||
| Income (loss) from continuing operations: | 40,772 | (225,821) | (109,751) | ||
| Income (loss) before gain (loss) on sale of properties: | 40,772 | (225,821) | (109,751) | ||
| Net income (loss) attributable to parent: | 40,772 | (225,821) | (109,751) | ||
| Preferred stock dividends and other adjustments | (20,100) | ||||
| Other undisclosed net loss available to common stockholders, basic | (13,492) | (7,792) | |||
| Net income (loss) available to common stockholders, diluted: | 27,280 | (233,613) | (129,851) | ||
Comprehensive Income ($ in thousands)
| 6/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|
| Net income (loss): | 40,772 | (225,821) | (109,751) | ||
| Comprehensive income (loss): | 40,772 | (225,821) | (109,751) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 329 | 127 | (430) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 41,101 | (225,694) | (110,181) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.